Editas Medicine, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+5.45%
vs ±18.5% implied · ×0.29
shaded = implied · ▲▼ = realized
No thesis.
Editas Medicine, Inc.
2.62
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | TCG Crossover ManagementTCG Crossover | $36.0M | 9.20% | new | |
| 2 | BlackRockBlackRockindex-like | $34.3M | 8.77% | +14.32% | |
| 3 | RA Capital ManagementRA Capital Management | $28.8M | 7.36% | new | |
| 4 | Commodore CapitalCommodore Capital | $28.8M | 7.36% | new | |
| 5 | ADAR1 Capital ManagementADAR1 | $28.8M | 7.36% | new | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $19.9M | 5.08% | +46.07% | |
| 7 | Paradigm Biocapital AdvisorsParadigm Biocapital | $18.1M | 4.62% | new | |
| 8 | Opaleye ManagementOpaleye | $12.5M | 3.20% | +100.41% | |
| 9 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $11.7M | 2.98% | +14.28% | |
| 10 | Woodline PartnersWoodline Partners | $11.5M | 2.94% | new | |
| 11 | Vivo CapitalVivo Capital | $11.5M | 2.94% | new | |
| 12 | GordonMD Global InvestmentsGordonMD Global | $10.1M | 2.59% | new | |
| 13 | Goldman Sachs GroupGoldman Sachs | $8.5M | 2.16% | +367.98% | |
| 14 | Geode Capital ManagementGeodeindex-like | $8.3M | 2.13% | +11.13% | |
| 15 | Renaissance TechnologiesRenaissance Technologies | $8.0M | 2.04% | −37.84% | |
| 16 | Logos Global ManagementLogos Global | $7.2M | 1.84% | new | |
| 17 | State StreetState Streetindex-like | $7.1M | 1.81% | +5.57% | |
| 18 | Marshall WaceMarshall Wace | $6.6M | 1.69% | +868.72% | |
| 19 | D. E. ShawD. E. Shaw | $6.2M | 1.57% | −2.21% | |
| 20 | JPMorgan ChaseJPMorgan Chase | $6.0M | 1.52% | new | |
| 21 | AQR Capital ManagementAQR | $5.1M | 1.30% | +14.72% | |
| 22 | Two Sigma InvestmentsTwo Sigma | $4.3M | 1.10% | −13.95% | |
| 23 | Seven Fleet Capital ManagementSeven Fleet | $4.3M | 1.10% | new | |
| 24 | Raymond James FinancialRaymond James Financial | $4.3M | 1.09% | +1.94% | |
| 25 | Acadian Asset ManagementAcadian | $3.4M | 0.86% | −28.72% |
215 managers report $391.4M of Editas Medicine on form 13F for the quarter ended Jun 30 '26. 21 of them hold 80% of it; TCG Crossover is largest at 9.20%.
Fund move
Fund move
Linked news
Expected move
Inputs8Q avg ±10.4%·×0.97·fair
straddle ±16.7%
spot 2.67exp Nov 20ATM strike 2.5ATM straddle 0.53IV 102%